This guy here is Louis Lange, founder, chairman and CEO of CV Therapeutics (CVTX). Last week, Lange and CVTX rejected a $1B buyout bid from Japanese big dawg Astellas. The bid was an all-cash offer. Yeah, all cash.

CVTX released a statement last week announcing the bid rejection, but Astellas is not backing down: they also released a statement…

“We are disappointed that CV Therapeutics’ Board has rejected our all cash proposal and did not engage us in any discussions as part of their review of our proposal. We continue to believe that our proposal provides CV Therapeutics’ stockholders excellent immediate value that exceeds what the company could reasonably expect to deliver through their standalone strategy. We remain committed to a transaction with CV Therapeutics, and while our desire continues to be to work together to negotiate a mutually agreeable transaction, we are considering all the options that are available to us to move our offer forward.”

We think Lange is suffering from founder’s syndrome. He founded CVTX back in 1992 and just can’t let go. CVTX is bordering on being a dog, bro. Let it go.

It’s a billion dollars dude – “ONE BILLION DOLLARS”

Image from daylife and affordablehousinginstitute

Related Posts